As part of its transformation plan, Damartex Group announced the acquisition of Santéol, a home healthcare provider specializing in the treatment of respiratory disorders and oxygen therapy. Founded in 2005 in Strasbourg, Santéol operates mainly in the Grand-Est and Provence-Alpes-Côte d’Azur regions and will generate in 2019 revenues and an Ebitda of approximately €8 million and €3.7 million respectively

Damartex is a group listed in Paris on Euronext Growth built around 11 strong brands, including Damart which has a revenues of more than €750 million. The acquisition of Santéol materializes the creation of a new Healthcare business unit and Damartex‘s ambition to diversify into the Silver Economy, a fast-growing sector. This new business unit will also include Sedagyl, a brand dedicated to home care services with revenues in France and the UK of €19.5 million for FY19. Damartex plans to expand its range of products and services and accelerate its growth in the digital sector for seniors and carers.